Cargando…
The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747130/ https://www.ncbi.nlm.nih.gov/pubmed/36330587 http://dx.doi.org/10.1111/cts.13385 |
_version_ | 1784849524039090176 |
---|---|
author | Moore, Ramey Purvis, Rachel S. Willis, Don E. Worley, Kyle C. Hervey, Devonte Reece, Sharon Yeates, Aimee McElfish, Pearl A. |
author_facet | Moore, Ramey Purvis, Rachel S. Willis, Don E. Worley, Kyle C. Hervey, Devonte Reece, Sharon Yeates, Aimee McElfish, Pearl A. |
author_sort | Moore, Ramey |
collection | PubMed |
description | Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuum encompassing a range of attitudes, beliefs, emotional orientations, ideologies, and health‐seeking behaviors. Individuals who received the COVID‐19 vaccine but also indicated some level of hesitancy about vaccination, or “hesitant adopters,” remain an understudied group. This study uses a qualitative descriptive design to understand motivations to receive the COVID‐19 vaccine among hesitant adopters at various self‐reported levels of hesitancy. We conducted interviews with hesitant adopters (n = 49) to analyze the elements of vaccine hesitancy corresponding to reported levels of COVID‐19 vaccine hesitancy (i.e., “little hesitant,” “somewhat hesitant,” and “very hesitant”). Concerns about side effects are shared across the continuum but are articulated differently at each level of hesitancy. The “little hesitant” relate fears of side effects to their health and a lack of clear information to inform their health decision making, whereas the “very hesitant” articulate the risks of side effects within the frame of conspiracies related to the development, approval, and economics of the COVID‐19 vaccine. Additionally, conspiracy theories generally increase in salience across the continuum, with the “very hesitant” reporting conspiracy theories as the most salient element of vaccine hesitancy. This research presents opportunities for developing targeted interventions for different levels of vaccine hesitancy. |
format | Online Article Text |
id | pubmed-9747130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97471302022-12-14 The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine Moore, Ramey Purvis, Rachel S. Willis, Don E. Worley, Kyle C. Hervey, Devonte Reece, Sharon Yeates, Aimee McElfish, Pearl A. Clin Transl Sci Research Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuum encompassing a range of attitudes, beliefs, emotional orientations, ideologies, and health‐seeking behaviors. Individuals who received the COVID‐19 vaccine but also indicated some level of hesitancy about vaccination, or “hesitant adopters,” remain an understudied group. This study uses a qualitative descriptive design to understand motivations to receive the COVID‐19 vaccine among hesitant adopters at various self‐reported levels of hesitancy. We conducted interviews with hesitant adopters (n = 49) to analyze the elements of vaccine hesitancy corresponding to reported levels of COVID‐19 vaccine hesitancy (i.e., “little hesitant,” “somewhat hesitant,” and “very hesitant”). Concerns about side effects are shared across the continuum but are articulated differently at each level of hesitancy. The “little hesitant” relate fears of side effects to their health and a lack of clear information to inform their health decision making, whereas the “very hesitant” articulate the risks of side effects within the frame of conspiracies related to the development, approval, and economics of the COVID‐19 vaccine. Additionally, conspiracy theories generally increase in salience across the continuum, with the “very hesitant” reporting conspiracy theories as the most salient element of vaccine hesitancy. This research presents opportunities for developing targeted interventions for different levels of vaccine hesitancy. John Wiley and Sons Inc. 2022-11-03 2022-12 /pmc/articles/PMC9747130/ /pubmed/36330587 http://dx.doi.org/10.1111/cts.13385 Text en © 2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Moore, Ramey Purvis, Rachel S. Willis, Don E. Worley, Kyle C. Hervey, Devonte Reece, Sharon Yeates, Aimee McElfish, Pearl A. The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine |
title | The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine |
title_full | The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine |
title_fullStr | The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine |
title_full_unstemmed | The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine |
title_short | The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine |
title_sort | vaccine hesitancy continuum among hesitant adopters of the covid‐19 vaccine |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747130/ https://www.ncbi.nlm.nih.gov/pubmed/36330587 http://dx.doi.org/10.1111/cts.13385 |
work_keys_str_mv | AT mooreramey thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT purvisrachels thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT willisdone thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT worleykylec thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT herveydevonte thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT reecesharon thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT yeatesaimee thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT mcelfishpearla thevaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT mooreramey vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT purvisrachels vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT willisdone vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT worleykylec vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT herveydevonte vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT reecesharon vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT yeatesaimee vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine AT mcelfishpearla vaccinehesitancycontinuumamonghesitantadoptersofthecovid19vaccine |